Filing Flows › Sanofi (SNY) › Q1 2025
Sanofi (SNY) Q1 2025 earnings results (first quarter 2025)
6-K filed Apr 24, 2025
Sanofi (SNY) reported revenue of $9.9B for the first quarter 2025 (Q1 2025), +11% from a year earlier. Operating margin was 23.1%, net earnings $1.9B (18.9% of revenue).
Sanofi, Q1 2025: revenue $9.9B (+11% year over year), operating margin 23.1%, net earnings $1.9B, operating cash flow $2.1B. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.9B | — | +11% |
| Gross profit | $7.7B | — | +14% |
| Operating profit | $2.3B | — | +85% |
| Net earnings | $1.9B | — | +65% |
| Operating cash flow | $2.1B | — | 24× |
What changed
Revenue was €9.9B in Q1 2025, up 11% year over year.
Gross margin was 78.0%, up 2.3 points from a year earlier. Operating profit was €2.3B, a 23.1% margin (up 9.3 points year over year). Of the extra revenue versus a year earlier, 109% reached operating profit, above the 14% margin then. Operating expenses fell 2% while revenue rose 11%. Net earnings were €1.9B, up 65% year over year. The effective tax rate was 20.3%.
Operating cash flow was €2.1B (up 2278% year over year), 111% of net earnings. Working capital and other items added €0.20B.
Questions
What was Sanofi's revenue in the first quarter 2025?
Sanofi (SNY) reported revenue of $9.9B for the first quarter 2025 (Q1 2025), +11% from a year earlier.
Was Sanofi profitable in the first quarter 2025?
Operating profit was $2.3B (23.1% of revenue) and net earnings $1.9B.
Source: Sanofi 6-K on SEC EDGAR.